Position in TMO
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$894,927
-$120,082 QoQ
Shares Held
1,785
-13.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#1,495
of 2,602 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026111 Capital holds $4,644,236 across 6 Diagnostics & Research names. TMO ranks #3 (19.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
9,431 | $1,252,719 | |
| 2 | WAT |
Waters Corp /De/
|
2,395 | $898,220 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
This page
|
1,785 | $894,927 | |
| 4 | GH |
Guardant Health, Inc.
|
4,916 | $737,547 | |
| 5 | LH |
Labcorp Holdings Inc.
|
1,888 | $528,640 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
631 | $332,183 |
All Filings in TMO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $894,927 | 1,785 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,015,009 | 2,065 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $665,788 | 1,149 | Shares | Sole | 2026-02-11 | |
| 2025-06-30 | $3,349,505 | 8,261 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $1,643,572 | 3,303 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $588,380 | 1,131 | Shares | Sole | 2025-03-18 | |
| No filing history on record for this holder in this stock. | ||||||